Specific labelling of cell populations in blood with targeted immuno-fluorescent/magnetic glyconanoparticles

Biomaterials

Volumn 32, Issue 36, 2011, Pages 9818-9825

  Gallo, Juan ^a   García, Isabel ^a,b   Genicio, Nuria ^a   Padro, Daniel ^a   Penadés, Soledad ^a,b  

^a CIC BIOMAGUNE   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Fluorescence microscopy; Fluorescent magnetic nanoparticles; Human blood cells; Magnetic resonance imaging; Specific labelling

Indexed keywords

BIOLOGICAL CONDITIONS; BIOLOGICAL MEDIUM; CELL POPULATIONS; CELLULAR LEVELS; CLINICAL USE; CONTRAST AGENT; COVALENT COUPLINGS; CURRENT PERFORMANCE; FLUORESCENT/MAGNETIC NANOPARTICLES; GOLD-COATED; HAEMOGLOBINS; HUMAN BLOOD CELLS; HUMAN BLOODS; IN-VIVO; IRON CONTENT; METASTATIC CANCER CELLS; MULTI-MODAL; PERIPHERAL BLOOD MONONUCLEAR CELLS; PROTEIN CONTENTS; PROTEIN G; RED BLOOD CELL; SPECIFIC LABELLING; THERAPEUTIC TOOLS;

BIOSYNTHESIS; BLOOD; CELL CULTURE; CELL PROLIFERATION; FERRITES; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GOLD COATINGS; IRON ORES; IRON OXIDES; MAGNETIC RESONANCE IMAGING; NANOMAGNETICS; NANOPARTICLES; PROBES; RESONANCE; TISSUE;

STEM CELLS;

IMMUNOFLUORESCENT MAGNETIC GLYCONANOPARTICLE; IMMUNOGLOBULIN G ANTIBODY; MAGNETITE; NANOPARTICLE; PROTEIN G; UNCLASSIFIED DRUG;

ARTICLE; CELL LABELING; CELL POPULATION; ERYTHROCYTE; FLUORESCENCE MICROSCOPY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

BLOOD CELLS; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSIDES; HUMANS; MAGNETIC PHENOMENA; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; STAINING AND LABELING;

EID: 80054089403     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.09.010     Document Type: Article

References (46)

1. De M., Ghosh P.S., Rotello V.M. Application of nanoparticles in biology. Adv Mater 2008, 20:1-17.
2. Gao J., Gu H., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res 2009, 42:1097-1107.
3. Jun Y.W., Lee J.H., Cheon J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed 2008, 47:5122-5135.
4. Cheon J., Lee J.H. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res 2008, 41:1630-1640.
5. Fang C., Zhang M. Multifunctional magnetic nanoparticles for medical imaging applications. J Mater Chem 2009, 19:6258-6266.
6. Sun C., Lee J.S., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliver Rev 2008, 60:1252-1265.
7. Semelka R.C., Helmberger T.K. Contrast agents for MR imaging of the liver. Radiology 2001, 218:27-38.
8. Reimer P., Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 1998, 8:1198-1204.
9. Weissleder R., Elizondo G., Wittenberg J., Rabito C.A., Bengele H.H., Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990, 175:489-493.
10. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New Engl J Med 2003, 348:2491-2499.
11. Corot C., Robert P., Idee J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliver Rev 2006, 58:1471-1504.
12. Mi Y., Liu Y., Guo Y., Feng S.S. Herceptin(R)-conjugated nanocarriers for targeted imaging and treatment of HER2-positive cancer. Nanomedicine-UK 2011, 6:311-312.
13. Hu F., Wei L., Zhou Z., Ran Y., Li Z., Gao M. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer. Adv Mater 2006, 18:2553-2556.
14. Lee J.H., Huh Y.M., Jun Y.W., Seo J.W., Jang J.T., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
15. Zhao M., Kircher M.F., Josephson L., Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem 2002, 13:840-844.
16. Zhang C., Jugold M., Woenne E.C., Lammers T., Morgenstern B., Mueller M.M., et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 2007, 67:1555-1562.
17. 4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. J Am Chem Soc 2008, 130:7542-7543.
18. Kircher M.F., Allport J.R., Graves E.E., Love V., Josephson L., Lichtman A.H., et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003, 63:6838-6846.
19. Chen T.J., Cheng T.H., Hung Y.C., Lin K.T., Liu G.C., Wang Y.M. Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI. J Biomed Mater Res A 2008, 87:165-175.
20. Kumagai M., Sarma T.K., Cabral H., Kaida S., Sekino M., Herlambang N., et al. Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. Macromol Rapid Comm 2010, 31:1521-1528.
21. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007, 2:469-478.
22. Owens D.E., Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006, 307:93-102.
23. Lacerda S.H., Park J.J., Meuse C., Pristinski D., Becker M.L., Karim A., et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 2010, 4:365-379.
24. Ma L.L., Jie P., Venkatraman S.S. Block copolymer stealth nanoparticles for chemotherapy: interactions with blood cells in vitro. Adv Funct Mater 2008, 18:716-725.
25. Dobrovolskaia M.A., Patri A.K., Zheng J., Clogston J.D., Ayub N., Aggarwal P., et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed-Nanotechnol 2009, 5:106-117.
26. Hall J.B., Dobrovolskaia M.A., Patri A.K., McNeil S.E. Characterization of nanoparticles for therapeutics. Nanomedicine-UK 2007, 2:789-803.
27. Gallo J., García I., Padro D., Arnáiz B., Penadés S. Water-soluble magnetic glyconanoparticles based on metal-doped ferrites coated with gold: synthesis and characterization. J Mater Chem 2010, 20:10010-10020.
28. Garcia I., Gallo J., Genicio N., Padro D., Penades S. Magnetic glyconanoparticles as a versatile platform for selective immunolabeling and imaging of cells. Bioconjug Chem 2011, 22:264-273.
29. Mu Q.L.Z., Li X., Mishra S.R., Zhang B., Si Z., Yang L., et al. Characterization of protein clusters of diverse magnetic nanoparticles and their dynamic interactions with human cells. J Phys Chem C 2009, 113:5390-5395.
30. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
31. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991, 3:207-212.
32. Seager Danciger J., Lutz M., Hama S., Cruz D., Castrillo A., Lazaro J., et al. Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J Immunol Methods 2004, 288:123-134.
33. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003, 7:626-634.
34. Charbonneau H., Tonks N.K., Walsh K.A., Fischer E.H. The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc Natl Acad Sci USA 1988, 85:7182-7186.
35. Cruse J.M., Lewis R.E., Wang H. Immunology guidebook 2004, Elsevier Academic Press, London, UK.
36. Terstappen L.W., Hollander Z., Meiners H., Loken M.R. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol 1990, 48:138-148.
37. Bikoue A., Janossy G., Barnett D. Stabilised cellular immuno-fluorescence assay: CD45 expression as a calibration standard for human leukocytes. J Immunol Methods 2002, 266:19-32.
38. Tomita M., Furthmayr H., Marchesi V.T. Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence. Biochemistry 1978, 17:4756-4770.
39. Koziara J.M., Oh J.J., Skers W.S., Ferraris S.P., Mumper R.J. Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res 2005, 22:1821-1828.
40. Repnik U., Knezevic M., Jeras M. Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods 2003, 278:283-292.
41. Kim J., Kim J.-M. Fluorescence quenching of a partially conjugated polymer by hemoglobin. Macromol Res 2007, 15:90-92.
42. Deumie M., El Baraka M., Quinones E. Fluorescence quenching of pyrene derivatives by iodide compounds in erythrocyte membranes: an approach of the probe location. J Photoch Photobio A 1995, 87:105-113.
43. Crowley J.B., Birkmeyer R.C., Tan-Wilson A.L. Additional antigenic sites on human hemoglobin evident upon separation of antibody populations. Mol Immunol 1980, 17:1449-1457.
44. Wilson D.H., Bogacz J.P., Forsythe C.M., Turk P.J., Lane T.L., Gates R.C., et al. Fully automated assay of glycohemoglobin with the Abbott IMx analyzer: novel approaches for separation and detection. Clin Chem 1993, 39:2090-2097.
45. Lissi E.A., Caceres T. Oxygen diffusion-concentration in erythrocyte plasma membranes studied by the fluorescence quenching of anionic and cationic pyrene derivatives. J Bioenerg Biomembr 1989, 21:375-385.
46. Stokke T., Holte H., Davies C.D., Steen H.B., Lie S.O. Quenching of Hoechst 33258 fluorescence in erythroid precursors. Cytometry 1990, 11:686-690.